Zuoshang Xu

This inventor holds 11 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: University of Massachusetts. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zuoshang Xu. Retrieved from https://idiyas.com/inventor/zuoshang-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 6)

% Patents Active = 81.8

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 207(Granted Patents)

Location History:

North Grafton, MA (US) (2009 - 2011)
Wellesley, MA (US) (2011 - 2020)

Company Filing History:

11 out of 1,627

University of Massachusetts

patents

Years Active: 2009-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680111 - SYNTHETIC PROMOTERS FOR GENE THERAPY AND PROTEIN EXPRESSION (2026-07-14),

2. 10731178 - CNS targeting AAV vectors and methods of use thereof (2020-08-04),

3. 9701984 - CNS targeting AAV vectors and methods of use thereof (2017-07-11),

4. 9663586 - Anti-SOD1 antibodies and uses thereof (2017-05-30),

5. 9109037 - Anti-SOD1 antibodies and uses thereof (2015-08-18),

6. 9102949 - CNS targeting AAV vectors and methods of use thereof (2015-08-11),

7. 8309533 - Allele-specific RNA interference (2012-11-13),

8. 8008271 - Methods and compositions for treating gain-of-function disorders using RNA interference (2011-08-30),

9. 7951784 - RNA interference agents for therapeutic use (2011-05-31),

10. 7892793 - Allele-specific RNA interference (2011-02-22),

11. 7498316 - Methods and compositions for treating gain-of-function disorders using RNA interference (2009-03-03),

Title: The Innovations of Zuoshang Xu: Pioneering CNS Targeting AAV Vectors

Introduction

Zuoshang Xu, based in Wellesley, MA, is a remarkable inventor recognized for his significant contributions to the field of biotechnology. With a portfolio boasting 10 patents, he continues to push the boundaries of research and innovation, particularly in developing adeno-associated viruses aimed at treating central nervous system (CNS) disorders.

Latest Patents

Among his most notable inventions are the patents related to CNS targeting AAV vectors and methods of use thereof. These innovations focus on the utilization of recombinant adeno-associated viruses to target transgenes specifically to CNS tissue. Furthermore, these patents encompass compositions that leverage these vectors and provide methods for treating various CNS-related disorders, demonstrating the potential for substantial advancements in therapeutic approaches.

Career Highlights

Throughout his career at the University of Massachusetts, Xu has established himself as a leader in his field, utilizing his expertise to advance human health. His work not only contributes to scientific knowledge but also offers viable solutions for addressing challenging medical conditions affecting the CNS.

Collaborations

Zuoshang Xu has collaborated with esteemed colleagues, including Guangping Gao and Hongwei Zhang. These partnerships have been instrumental in enhancing the scope and impact of his research, as they collectively work towards innovative solutions in gene therapy and related biotechnologies.

Conclusion

As a prominent inventor, Zuoshang Xu exemplifies the spirit of innovation that drives advancements in medicine and biotechnology. His work in CNS targeting AAV vectors represents a vital step forward in the ongoing quest to develop effective treatments for neurological disorders, thereby improving the quality of life for countless individuals.

Profile summary based on public USPTO records.